✦ LIBER ✦

770 CHARACTERIZATION OF THE HEPATOSELECTIVE DISTRIBUTION OF ACH-1625, A POTENT, CLINICAL STAGE HCV NS3 PROTEASE INHIBITOR

✍ Scribed by K. Stauber; C.W. Marlor; G. Mushtaq; V. Gadhachanda; G. Pais; A. Hashimoto; A. Phadke; M. Huang; M. Deshpande

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

650 ANTIVIRAL ACTIVITY, COMBINATION AND

✍ M. Huang; J. Fabrycki; D. Patel; S. Podos; G. Yang; Y. Zhao; C.W. Marlor; K. Sta 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Highly Potent Non-peptidic Inhibitors of

✍ David Sperandio; et al. et al. 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 77 KB 👁 2 views

458 FINAL RESULTS OF THE PHARMACOKINETIC

✍ V. Detishin; W. Haazen; R. Hooijmaijers; M. Ruppert; K. Bol; H. Robison; L. Roba 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Cross-species absorption, metabolism, di

✍ Duan, Jianmin; Yong, Chan-Loi; Garneau, Michel; Amad, Ma’an; Bolger, Gordon; De 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 771 KB

954 BI 201335, A POTENT HCV NS3 PROTEASE

✍ G. Kukolj; Y. Benhamou; M.P. Manns; M. Bourlière; S. Pol; M. Schuchmann; M. Cart 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

1182 CHARACTERIZATION OF HCV NS3 PROTEAS

✍ Fabrycki, J.; Patel, D.; Yang, G.; Zhao, Y.; Podos, S.; Robison, H.; Robarge, L. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB